JohnPVavalleMD

Interventional Cardiology

Associate Professor of Medicine, UNC Chapel Hill; Adjunct Assistant Professor of Medicine, Duke University; Medical Director, Structural Heart Disease Program; Associate Program Director, Cardiology Fellowship; Associate Program Director, Interventional Cardiology Fellowship.

Join to view full profile

Dr. Vavalle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vavalle's full profile

Already have an account?

Office
101 Manning Dr
CB 7050.
Chapel Hill, NC 27599
Phone+1 919-966-4131

Fax+1 919-966-1743

Summary

UNC Patient Stories: TAVR

When 88-year-old Tony Sciturro had a hard time breathing, he knew something was wrong. As an older patient with aortic valve stenosis, TAVR was the answer.

Education & Training

Duke University HospitalFellowship, Interventional Cardiology, 2012 - 2013
Duke University HospitalFellowship, Cardiovascular Disease, 2008 - 2012
University of North Carolina HospitalsResidency, Internal Medicine, 2004 - 2008
University of North Carolina at Chapel Hill School of MedicineClass of 2004

Certifications & Licensure

NC State Medical License 2004 - 2025
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Alpha Omega Alpha University of North Carolina, 2016

Clinical Trials

Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Start of enrollment: 2014 May 01
Recruiting
Not Applicable
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR Start of enrollment: 2018 Jan 01
Recruiting
Not Applicable

Publications & Presentations

PubMed

79 citations
Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond
Adam Chakos, Ashley Wilson-Smith, Sameer Arora, Tom C. Nguyen, Abhijeet Dhoble
Annals of Cardiothoracic Surgery. 2017-09-01
6 citations
Predicting need for pacemaker implantation early and late after transcatheter aortic valve implantation.
Anthony J. Mazzella, Mason Sanders, Hannan Yang, Quefeng Li, John P. Vavalle
Catheterization and Cardiovascular Interventions. 2021-03-01
6 citations
Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement.
Anthony J. Mazzella, Sameer Arora, Michael Hendrickson, Mason Sanders, John P. Vavalle
Cardiac Failure Review. 2021-07-27

Journal Articles

Atrial Fibrillation
John Vavalle, MD, JACC: Cardiovascular Imaging
Editorial Commentary: TAVR—Is There a Path to an All-Surgical-Risk Indication?
John Vavalle, MD, ScienceDirect

Authored Content

Netter's Cardiology 3rd Edition8/30/2018
Cardiovascular Hemodynamics for the Clinician, 2nd Edition3/1/2017

Press Mentions

Transcatheter Aortic Valve Replacement (TAVR) Associated with Shorter Hospital Stay, More Frequent Discharge to Home, Compared to Surgical Aortic Valve Replacement (SAVR)September 14th, 2018
A Heart Team and Multi-Modality Imaging Approach to Percutaneous Closure of a Post-Myocardial Infarction Ventricular Septal DefectApril 12th, 2016
TAVR Program Continues Growth, Fosters IntegrationJuly 23rd, 2016
Join now to see all